Correction: Change in Preferred Drug List Status for the Androgenic Agents (topical), Antiviral (oral/nasal), and Growth Hormone Drug Classes, Effective Oct. 16, 2023
For additional information, click here
* Required field
ATTENTION: By clicking Continue, you will leave the FirstCare Medicare Advantage pages. If you want to remain on these pages, click Cancel or close this box.